
As $2 bn legal storm brews, can India be Novo Nordisk’s safe haven?
While expanding its footprint in India for its diabetes and weight-loss drugs, Danish pharmaceutical giant Novo Nordisk could face potential legal liabilities of nearly $2 billion in the US, with more than 1,800 lawsuits consolidated in federal court in …